Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2416 AL 2430

The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease

Ling TS, Chandrasegaran S, Xuan LZ, Suan TL, Elaine E, Nathan DV, Chai YH, Gunasekaran B, Salvamani S.

Biomed Res Int. 2021 Jul 4;2021:5550938. doi: 10.1155/2021/5550938. eCollection 2021.

IL-33/ST2 Signaling Regulates Synaptic Plasticity and Homeostasis in the Adult Hippocampal Circuitry

Wang Y, Fu AKY, Ip NY.

DNA Cell Biol. 2021 Sep;40(9):1125-1130. doi: 10.1089/dna.2021.0491. Epub 2021 Jul 22.

Activity of Selected Group of Monoterpenes in Alzheimer's Disease Symptoms in Experimental Model Studies-A Non-Systematic Review

Wojtunik-Kulesza K, Rudkowska M, Kasprzak-Drozd K, Oniszczuk A, Borowicz-Reutt K.

Int J Mol Sci. 2021 Jul 8;22(14):7366. doi: 10.3390/ijms22147366.

Role of RhoA/ROCK signaling in Alzheimer's disease

Cai R, Wang Y, Huang Z, Zou Q, Pu Y, Yu C, Cai Z.

Behav Brain Res. 2021 Sep 24;414:113481. doi: 10.1016/j.bbr.2021.113481. Epub 2021 Jul 21.

Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer's disease

Ding XW, Robinson M, Li R, Aldhowayan H, Geetha T, Babu JR.

Pharmacol Res. 2021 Sep;171:105783. doi: 10.1016/j.phrs.2021.105783. Epub 2021 Jul 22.

Chemical update on the potential for serotonin 5-HT(6) and 5-HT(7) receptor agents in the treatment of Alzheimer's disease

Kucwaj-Brysz K, Baltrukevich H, Czarnota K, Handzlik J.

Bioorg Med Chem Lett. 2021 Oct 1;49:128275. doi: 10.1016/j.bmcl.2021.128275. Epub 2021 Jul 23.

Alzheimer's trials: A cul-de-sac with no end in sight

Kurkinen M.

Adv Clin Exp Med. 2021 Jul;30(7):653-654. doi: 10.17219/acem/139501.

Role of metals in Alzheimer's disease

Das N, Raymick J, Sarkar S.

Metab Brain Dis. 2021 Oct;36(7):1627-1639. doi: 10.1007/s11011-021-00765-w. Epub 2021 Jul 27.

Alzheimer's disease: the controversial approval of Aducanumab

Tagliavini F, Tiraboschi P, Federico A.

Neurol Sci. 2021 Aug;42(8):3069-3070. doi: 10.1007/s10072-021-05497-4. Epub 2021 Jul 29.

Metal Complexation Mechanisms of Polyphenols Associated to Alzheimer's Disease

Kola A, Dudek D, Valensin D.

Curr Med Chem. 2021;28(35):7278-7294. doi: 10.2174/0929867328666210729120242.

Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer's disease

Handa M, Tiwari S, Yadav AK, Almalki WH, Alghamdi S, Alharbi KS, Shukla R, Beg S.

Drug Discov Today. 2021 Dec;26(12):2881-2888. doi: 10.1016/j.drudis.2021.07.020. Epub 2021 Jul 29.

In vivo functions of p75(NTR): challenges and opportunities for an emerging therapeutic target

Malik SC, Sozmen EG, Baeza-Raja B, Le Moan N, Akassoglou K, Schachtrup C.

Trends Pharmacol Sci. 2021 Sep;42(9):772-788. doi: 10.1016/j.tips.2021.06.006. Epub 2021 Jul 29.

Pilot evaluation of a consumer wearable device to assess sleep in a clinical polysomnography trial of suvorexant for treating insomnia in patients with Alzheimer's disease

Svetnik V, Wang TC, Ceesay P, Snyder E, Ceren O, Bliwise D, Budd K, Hutzelmann J, Stevens J, Lines C, Michelson D, Herring WJ.

J Sleep Res. 2021 Dec;30(6):e13328. doi: 10.1111/jsr.13328. Epub 2021 Aug 2.

Use of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease: A Systematic Review

Cardinali CAEF, Martins YA, Torrão AS.

Drugs Aging. 2021 Sep;38(9):769-791. doi: 10.1007/s40266-021-00878-y. Epub 2021 Aug 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias